English | Español

Merck
Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance
Russell Boniface | Sep 13, 2017

Merck's Keytruda wins European approval as bladder cancer treatment

Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe

Trending
+ Community
Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+ Regulatory
Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+ Pharmaceuticals
Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts